Interim Director, Division of Hematology
Dr. Benson is an oncologist and hematologist caring for patients with multiple myeloma, amyloidosis and other blood cancers. He is also actively involved in clinical and laboratory-based research to develop new treatments and approaches to these conditions.
As a hematologist-oncologist, Dr. Long has a special interest in treating patients with chronic lymphocytic leukemia (CLL). His research focus has been on developing novel therapeutics that will boost the patient’s immune system to naturally fight the disease. Presently, I’m clinical instructor in hematology-oncology.
Dr. Maddocks is an associate professor of clinical internal medicine in the Division of Hematology. Her job includes working as a hematologist specializing in treating patients with B-cell malignancies, including non-Hodgkin lymphoma, Hodgkin lymphoma and chronic lymphocytic Leukemia, and researching new therapies for these hematologic malignancies, largely through evaluating new targeted therapies in clinical trials.
Dr. Walker is an oncologist treating patients with leukemia and other blood cancers. Her specific areas of focus include acute myeloid leukemias (AML) and myelodysplastic syndromes. I serve as an associate professor in the Division of Hematology and director of the Hematology and Medical Oncology Fellowship Program.
Dr. Oakes is an assistant professor of Internal Medicine. His current research focuses on investigating the role of epigenetics in hematological malignancies, with a primary focus on understanding the evolution and impact of epigenetic programming on the cancer cell phenotype.
Lynn O'Donnell, PhD
Dr. O'Donnell is an associate professor of Internal Medicine. Her research interests novel cellular therapies for malignancies and regenerative medicine, translational development, GMP manufacturing, IND and IDE submissions for FDA
Parvathi Ranganathan, PhD
Dr. Ranganathan is a research assistant professor. Her research interests include immunobiology of aGVHD, non-coding RNAs in aGVHD, experimental therapeutics in aGVHD
The James Cancer Network
Yaser Al-Marrawi, MD
Dr. Al-Marrawi is a physician in the Division of Hematology.
Dr. Rupert is a general medical oncologist with additional focus on hematology and thrombosis. He has extensive experience treating patients with solid tumors and hematologic disorders. He serves as medical director of oncology at JamesCare at University Hospital East and as an assistant professor in the Department of Internal Medicine.